$EDGE PDS Biotechnology Corp Insider Trading Week 11/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PDS Biotechnology Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PDS Biotechnology Corp in week 11/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Macdonald R. Loch | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Macdonald R. Loch | Director | Buy | M | 0.00 | 10,000 | 0 | 580,602 | 570.6 K to 580.6 K (+1.75 %) |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Buy | M | 0.00 | 10,000 | 0 | 48,661 | 38.7 K to 48.7 K (+25.87 %) |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Saik Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 82,999 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Saik Andrew | Chief Financial Off ... | Buy | M | 0.00 | 82,999 | 0 | 82,999 | 0 to 83 K |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Ratcliffe Liam | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Ratcliffe Liam | Director | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | MIDDLEKAUFF W BRADFORD | Senior VP, GC and S ... | Option Exercise | M | 0.00 | 49,766 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | MIDDLEKAUFF W BRADFORD | Senior VP, GC and S ... | Buy | M | 0.00 | 49,766 | 0 | 59,766 | 10 K to 59.8 K (+497.66 %) |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | M | 0.00 | 10,000 | 0 | 26,625 | 16.6 K to 26.6 K (+60.15 %) |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Option Exercise | M | 0.00 | 169,032 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Buy | M | 0.00 | 169,032 | 0 | 239,268 | 70.2 K to 239.3 K (+240.66 %) |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | BLECH ISAAC | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | BLECH ISAAC | Director | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | BLECH ISAAC | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | BLECH ISAAC | Director | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Crane Rosemary A | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Crane Rosemary A | Director | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Buy | M | 0.00 | 20,000 | 0 | 678,075 | 658.1 K to 678.1 K (+3.04 %) |